163 related articles for article (PubMed ID: 11280613)
41. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
42. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
[TBL] [Abstract][Full Text] [Related]
43. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
[TBL] [Abstract][Full Text] [Related]
44. Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma.
Villalva C; Trempat P; Greenland C; Thomas C; Girard JP; Moebius F; Delsol G; Brousset P
Br J Haematol; 2002 Sep; 118(3):791-8. PubMed ID: 12181047
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma.
Agarwal S; Ramanathan U; Naresh KN
Hum Pathol; 2002 Feb; 33(2):146-52. PubMed ID: 11957137
[TBL] [Abstract][Full Text] [Related]
46. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.
ten Berge RL; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Oudejans JJ; Meijer JW; Willemze R; Hilgers J; Meijer CJ
J Clin Pathol; 2001 Dec; 54(12):933-9. PubMed ID: 11729213
[TBL] [Abstract][Full Text] [Related]
47. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma.
Dalton RR; Rassidakis GZ; Atwell C; Wang S; Oyarzo MP; Medeiros LJ
Hum Pathol; 2005 Jul; 36(7):806-11. PubMed ID: 16084951
[TBL] [Abstract][Full Text] [Related]
48. Complex variant translocation t(1;2) with TPM3-ALK fusion due to cryptic ALK gene rearrangement in anaplastic large-cell lymphoma.
Siebert R; Gesk S; Harder L; Steinemann D; Grote W; Schlegelberger B; Tiemann M; Wlodarska I; Schemmel V
Blood; 1999 Nov; 94(10):3614-7. PubMed ID: 10610119
[No Abstract] [Full Text] [Related]
49. The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas.
Raetz EA; Perkins SL; Carlson MA; Schooler KP; Carroll WL; Virshup DM
Am J Pathol; 2002 Sep; 161(3):875-83. PubMed ID: 12213716
[TBL] [Abstract][Full Text] [Related]
50. Truncated ALK derived from chromosomal translocation t(2;5)(p23;q35) binds to the SH3 domain of p85-PI3K.
Polgar D; Leisser C; Maier S; Strasser S; Rüger B; Dettke M; Khorchide M; Simonitsch I; Cerni C; Krupitza G
Mutat Res; 2005 Feb; 570(1):9-15. PubMed ID: 15680399
[TBL] [Abstract][Full Text] [Related]
51. A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation.
Adam P; Katzenberger T; Seeberger H; Gattenlöhner S; Wolf J; Steinlein C; Schmid M; Müller-Hermelink HK; Ott G
Am J Surg Pathol; 2003 Nov; 27(11):1473-6. PubMed ID: 14576483
[TBL] [Abstract][Full Text] [Related]
52. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK
Shi W; George SK; George B; Curry CV; Murzabdillaeva A; Alkan S; Amin HM
Mol Oncol; 2017 Sep; 11(9):1189-1207. PubMed ID: 28557340
[TBL] [Abstract][Full Text] [Related]
53. TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.
Armstrong F; Lamant L; Hieblot C; Delsol G; Touriol C
Eur J Cancer; 2007 Mar; 43(4):640-6. PubMed ID: 17276053
[TBL] [Abstract][Full Text] [Related]
54. Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy.
Coluccia AM; Gunby RH; Tartari CJ; Scapozza L; Gambacorti-Passerini C; Passoni L
Expert Opin Ther Targets; 2005 Jun; 9(3):515-32. PubMed ID: 15948671
[TBL] [Abstract][Full Text] [Related]
55. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
56. Expression of anaplastic lymphoma kinase in non-Hodgkin's lymphomas and other malignant neoplasms. Biological, diagnostic, and clinical implications.
Wasik MA
Am J Clin Pathol; 2002 Dec; 118 Suppl():S81-92. PubMed ID: 14569815
[TBL] [Abstract][Full Text] [Related]
57. The anaplastic lymphoma kinase in the pathogenesis of cancer.
Chiarle R; Voena C; Ambrogio C; Piva R; Inghirami G
Nat Rev Cancer; 2008 Jan; 8(1):11-23. PubMed ID: 18097461
[TBL] [Abstract][Full Text] [Related]
58. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F
Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657
[TBL] [Abstract][Full Text] [Related]
59. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.
Hutchison RE; Banki K; Shuster JJ; Barrett D; Dieck C; Berard CW; Murphy SB; Link MP; Pick TE; Laver J; Schwenn M; Mathew P; Morris SW
Ann Oncol; 1997; 8 Suppl 1():37-42. PubMed ID: 9187427
[TBL] [Abstract][Full Text] [Related]
60. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
Bonvini P; Gastaldi T; Falini B; Rosolen A
Cancer Res; 2002 Mar; 62(5):1559-66. PubMed ID: 11888936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
